**SEO Title:** Fixderma’s Strategic Growth: Focus on Dermatology and Exports
**Meta Description:** Fixderma, backed by Lotus Herbals, targets 55% sales growth by focusing on dermatology products and controlled distribution channels.
**URL Slug:** fixderma-strategic-growth-dermatology-exports
**Headline:** Fixderma’s Strategic Focus on Dermatology Products Fuels Growth Plans
Fixderma, a skincare brand supported by Lotus Herbals, has reported a remarkable 30% increase in sales for the fiscal year 2024-25 and is aiming for a 55% growth in 2025-26. Co-founder and CEO Shaily Mehrotra attributes this success to a strategic focus on dermatology-led products and a controlled approach to channel growth, rather than high marketing expenditures or rapid category expansion. “We’re not looking to be everywhere or do everything. There’s still headroom in our core category,” Mehrotra stated.
Lotus Herbals holds a 30-32% stake in Fixderma, having invested ₹38 crore in 2021, but remains a non-operational partner, with Mehrotra noting, “There’s no day-to-day involvement. We report numbers quarterly.” Approximately ₹16 crore of the investment was allocated to debt clearance, while the remainder is being utilized gradually, with no immediate plans for further funding.
**Lean Operations and Limited Retail Expansion**
Fixderma operates two in-house manufacturing units established in 2012 and 2019, which allows for better cost control and production timelines. Unlike many new-age brands that outsource manufacturing, Mehrotra believes that direct production supports healthier margins and consistent quality. The brand has opted against large-scale retail expansion, maintaining only a single experience center in Gurugram, with no plans to replicate this model due to economic considerations.
Retail sales through pharmacy chains are on the rise, with Fixderma expanding its distribution network to include Apollo Pharmacy, Tata 1mg, and other medical retailers, particularly in the North East and West Bengal. Currently, retail accounts for about 5% of the company’s total sales.
**Diverse Sales Channels and Export Growth**
Fixderma’s revenue streams are diversified, with 40% coming from direct-to-consumer sales, 30% from doctor-led dermatology sales, and 25% from exports. The distributor channel, which encompasses exports and dermatology sales, reached an all-time high of $10 million in 2024. Vietnam has emerged as the brand’s strongest international market, followed by Malaysia, Cambodia, and Nepal. “Vietnam has become a high-performing market for us,” Mehrotra remarked, indicating plans to participate in upcoming trade fairs in Jakarta and Moscow.
In conclusion, Fixderma’s strategic focus on dermatology products, controlled growth, and export expansion positions the brand for continued success in the competitive skincare market.
**FAQ Section**
**Q: What is Fixderma’s growth strategy for the coming years?**
A: Fixderma aims for a 55% sales increase by focusing on dermatology-led products and controlled distribution channels, rather than extensive marketing or rapid retail expansion.
